SEC Form D · Amendment · filed July 19, 2019
Finch Therapeutics Group, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (22)
Carter G. Mcnabb · Louisville, CODirectorMatthew N. Whitehead · Hong Kong, Hong KongExec · DirectorBryan Y. Colwell · New York, NYDirectorMichael Galgon · Seattle, WADirectorAlexander T. Edwards · Boston, MAExecUlrich A. Thienel · Somerville, MAExecKerry Song · San Clemente, CAExecGreg A. Perry · Somerville, MAExecJackie N. Charlesworth · Hong Kong, Hong KongDirectorRuoyu Wang · San Francisco, CADirectorPatrick Dunn · PROVIDENCE, RIExecReiji Morooka · Tokyo, M0DirectorMarc N. Puglia · PROVIDENCE, RIExecAllison Harr · Seattle, WADirectorBracken T. Darrell · Boston, MAExec · DirectorGabriel Haddad Silva · Grand Cayman, Cayman IslandsDirectorHarry W. Lengsfield · NEW YORK, NYExecMilton Berlinski · New York, NYDirectorTodd Haskins · New York, NYExecPeter Aberg · New York, NYDirectorDavid T. Sinclair · Boston, MAExecLair G. Kennedy · Louisville, COExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗